New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cells

Detalhes bibliográficos
Autor(a) principal: Santos, Jucimary V.
Data de Publicação: 2013
Outros Autores: Pina, Maria Eugénia T., Marques, M. P. M., Carvalho, Luís A. E. Batista de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/25649
https://doi.org/10.3109/03639045.2012.669129
Resumo: Objective: The aim of this study was to adjust the zidovudine (AZT) release from solid tablets to an ideal profile, by developing matrices comprising swellable polymers with nonswellable ones. Methods: Directly compressed matrices comprised different ratios of hydroxypropylmethylcellulose K15M and K100M, ethylcellulose, and methacrylic acid (Eudragit® RS PO and Eudragit® RL PO) were prepared. Technological characterization and evaluation of the in vitro release behavior were carried out. Cell density and viability following drug exposure were evaluated by the SRB method, for the Caco-2 line, while cell morphology was assessed upon Trypan blue staining. Results: A specific formulation containing 5% of each excipient − HPMC K15M, HPMC K100M, Eudragit® RS PO, and Eudragit® RL PO − was found to yield the best release profile. Application of the Korsmeyer–Peppas model to the dissolution profile evidenced that a non-Fickian (anomalous) transport is involved in the drug release. Regarding the influence of the tablets’ composition on the drug’s cytotoxic effect toward the Caco-2 cell line, a reduction of cell biomass (0–15%) was verified for the distinct AZT formulations tested, F19 having displayed the highest cytotoxicity, after 24 and 48 h of incubation. Additionally, a high reversibility of the AZT effect was observed. Conclusions: The results showed that the simultaneous application of both hydrophilic and hydrophobic polymers can modulate the drug release process, leading to an improved efficacy and patient compliance. All AZT formulations studied were found to be cytotoxic against Caco-2 cells, F19 being the most effective one.
id RCAP_200aca1c381474b0c0d656da609fda5b
oai_identifier_str oai:estudogeral.uc.pt:10316/25649
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cellsZidovudine (AZT)hydroxypropylmethylcellulose (HPMC)Eudragit®in vitro releaseantiproliferative effectRaman spectroscopyObjective: The aim of this study was to adjust the zidovudine (AZT) release from solid tablets to an ideal profile, by developing matrices comprising swellable polymers with nonswellable ones. Methods: Directly compressed matrices comprised different ratios of hydroxypropylmethylcellulose K15M and K100M, ethylcellulose, and methacrylic acid (Eudragit® RS PO and Eudragit® RL PO) were prepared. Technological characterization and evaluation of the in vitro release behavior were carried out. Cell density and viability following drug exposure were evaluated by the SRB method, for the Caco-2 line, while cell morphology was assessed upon Trypan blue staining. Results: A specific formulation containing 5% of each excipient − HPMC K15M, HPMC K100M, Eudragit® RS PO, and Eudragit® RL PO − was found to yield the best release profile. Application of the Korsmeyer–Peppas model to the dissolution profile evidenced that a non-Fickian (anomalous) transport is involved in the drug release. Regarding the influence of the tablets’ composition on the drug’s cytotoxic effect toward the Caco-2 cell line, a reduction of cell biomass (0–15%) was verified for the distinct AZT formulations tested, F19 having displayed the highest cytotoxicity, after 24 and 48 h of incubation. Additionally, a high reversibility of the AZT effect was observed. Conclusions: The results showed that the simultaneous application of both hydrophilic and hydrophobic polymers can modulate the drug release process, leading to an improved efficacy and patient compliance. All AZT formulations studied were found to be cytotoxic against Caco-2 cells, F19 being the most effective one.J.V.S. acknowledges PhD fellowship from the Programme Alβan, the European Union Programme of High Level Scholarships for Latin America (scholarship no. E06D100103BR).Informa Healthcare2013info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/25649http://hdl.handle.net/10316/25649https://doi.org/10.3109/03639045.2012.669129enghttp://informahealthcare.com/doi/abs/10.3109/03639045.2012.669129Santos, Jucimary V.Pina, Maria Eugénia T.Marques, M. P. M.Carvalho, Luís A. E. Batista deinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2021-11-05T12:39:09Zoai:estudogeral.uc.pt:10316/25649Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:56:04.632847Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cells
title New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cells
spellingShingle New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cells
Santos, Jucimary V.
Zidovudine (AZT)
hydroxypropylmethylcellulose (HPMC)
Eudragit®
in vitro release
antiproliferative effect
Raman spectroscopy
title_short New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cells
title_full New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cells
title_fullStr New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cells
title_full_unstemmed New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cells
title_sort New sustained release of Zidovudine Matrix tablets − cytotoxicity toward Caco-2 cells
author Santos, Jucimary V.
author_facet Santos, Jucimary V.
Pina, Maria Eugénia T.
Marques, M. P. M.
Carvalho, Luís A. E. Batista de
author_role author
author2 Pina, Maria Eugénia T.
Marques, M. P. M.
Carvalho, Luís A. E. Batista de
author2_role author
author
author
dc.contributor.author.fl_str_mv Santos, Jucimary V.
Pina, Maria Eugénia T.
Marques, M. P. M.
Carvalho, Luís A. E. Batista de
dc.subject.por.fl_str_mv Zidovudine (AZT)
hydroxypropylmethylcellulose (HPMC)
Eudragit®
in vitro release
antiproliferative effect
Raman spectroscopy
topic Zidovudine (AZT)
hydroxypropylmethylcellulose (HPMC)
Eudragit®
in vitro release
antiproliferative effect
Raman spectroscopy
description Objective: The aim of this study was to adjust the zidovudine (AZT) release from solid tablets to an ideal profile, by developing matrices comprising swellable polymers with nonswellable ones. Methods: Directly compressed matrices comprised different ratios of hydroxypropylmethylcellulose K15M and K100M, ethylcellulose, and methacrylic acid (Eudragit® RS PO and Eudragit® RL PO) were prepared. Technological characterization and evaluation of the in vitro release behavior were carried out. Cell density and viability following drug exposure were evaluated by the SRB method, for the Caco-2 line, while cell morphology was assessed upon Trypan blue staining. Results: A specific formulation containing 5% of each excipient − HPMC K15M, HPMC K100M, Eudragit® RS PO, and Eudragit® RL PO − was found to yield the best release profile. Application of the Korsmeyer–Peppas model to the dissolution profile evidenced that a non-Fickian (anomalous) transport is involved in the drug release. Regarding the influence of the tablets’ composition on the drug’s cytotoxic effect toward the Caco-2 cell line, a reduction of cell biomass (0–15%) was verified for the distinct AZT formulations tested, F19 having displayed the highest cytotoxicity, after 24 and 48 h of incubation. Additionally, a high reversibility of the AZT effect was observed. Conclusions: The results showed that the simultaneous application of both hydrophilic and hydrophobic polymers can modulate the drug release process, leading to an improved efficacy and patient compliance. All AZT formulations studied were found to be cytotoxic against Caco-2 cells, F19 being the most effective one.
publishDate 2013
dc.date.none.fl_str_mv 2013
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/25649
http://hdl.handle.net/10316/25649
https://doi.org/10.3109/03639045.2012.669129
url http://hdl.handle.net/10316/25649
https://doi.org/10.3109/03639045.2012.669129
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://informahealthcare.com/doi/abs/10.3109/03639045.2012.669129
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Informa Healthcare
publisher.none.fl_str_mv Informa Healthcare
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133846081372160